The Pharmacy Guild of New Zealand (the Guild) welcomes
yesterdays announcement which saw Pharmac receive a $604
million funding boost over four years, allowing then to
deliver an overall package of up to 54 new medicines,
including up to 26 cancer treatments.
Pharmac
estimates that around 175,000 people will benefit from
medicines made available with the additional funding in the
first year.
“The additional funding for Pharmac will
not only provide more comprehensive treatment options for
patients but will also improve overall healthcare outcomes
for our patients. We are delighted to see the government
taking such a proactive approach to addressing the needs of
our communities,” says Guild President, Kesh
Naidoo-Rauf.
“The increased funding will
enable Pharmac to expand its range of available treatments,
ensuring that patients have access to the most effective and
up-to-date medicines. This should alleviate some of the
financial burdens faced by patients and their families,
providing them with better prospects for
recovery.
“We look forward to providing
feedback to Pharmac to ensure the benefits of this funding
are maximised. Community pharmacies play a vital role in the
distribution of medicines nationwide, ensuring patients
receive the correct medicine as quickly as possible – this
includes ensuring the medicine is appropriate for the
patient, that there are no potential interactions with other
medicines the patient is taking, and providing instructions
for use and on potential side effects.
Advertisement – scroll to continue reading
“By working
together, we can ensure that expanded access to medicines
translates into health improvements for New Zealanders,”
says Ms
Naidoo-Rauf.
Notes:
•
The Guild is a membership organisation representing
community pharmacy owners throughout New
Zealand.
• We provide leadership on all
issues affecting members and advocate for their business and
professional
interests.
© Scoop Media
Advertisement – scroll to continue reading